- Home
- KMDA vs ACNB Comparison
KMDA vs ACNB Comparison
Compare KMDA & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- ACNB
- Stock Information
- Founded
- KMDA 1990
- ACNB 1857
- Country
- KMDA Israel
- ACNB United States
- Employees
- KMDA N/A
- ACNB N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- ACNB Major Banks
- Sector
- KMDA Health Care
- ACNB Finance
- Exchange
- KMDA Nasdaq
- ACNB Nasdaq
- Market Cap
- KMDA 349.1M
- ACNB 405.4M
- IPO Year
- KMDA N/A
- ACNB N/A
- Fundamental
- Price
- KMDA $6.47
- ACNB $41.36
- Analyst Decision
- KMDA Strong Buy
- ACNB Strong Buy
- Analyst Count
- KMDA 3
- ACNB 4
- Target Price
- KMDA $14.67
- ACNB $50.00
- AVG Volume (30 Days)
- KMDA 106.2K
- ACNB 37.9K
- Earning Date
- KMDA 05-07-2025
- ACNB 05-02-2025
- Dividend Yield
- KMDA 3.10%
- ACNB 3.10%
- EPS Growth
- KMDA 66.67
- ACNB 0.54
- EPS
- KMDA 0.25
- ACNB 3.73
- Revenue
- KMDA $160,953,000.00
- ACNB $111,104,000.00
- Revenue This Year
- KMDA $14.01
- ACNB $35.65
- Revenue Next Year
- KMDA $9.24
- ACNB $7.15
- P/E Ratio
- KMDA $25.58
- ACNB $11.06
- Revenue Growth
- KMDA 12.93
- ACNB 4.89
- 52 Week Low
- KMDA $4.74
- ACNB $30.24
- 52 Week High
- KMDA $9.15
- ACNB $50.72
- Technical
- Relative Strength Index (RSI)
- KMDA 49.43
- ACNB 56.46
- Support Level
- KMDA $6.36
- ACNB $39.75
- Resistance Level
- KMDA $6.57
- ACNB $41.18
- Average True Range (ATR)
- KMDA 0.28
- ACNB 1.68
- MACD
- KMDA 0.06
- ACNB 0.19
- Stochastic Oscillator
- KMDA 76.23
- ACNB 94.25
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.